Status:
UNKNOWN
Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers
Lead Sponsor:
Centre Francois Baclesse
Conditions:
COVID-19
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This original study will assess the impact of the coronavirus health crisis on the management of patients undergoing medical treatment for cancer, in particularly on the modification of the hospital o...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- For Patients:
- Adult patient, treated for a solid or hematological tumor
- will be treated ou actually treated by oncological treatment carried out at the hospital in day unit of the participating centers: treatment initiated before or during the pandemic with COVID-19
- For the Caregivers:
- \- Medical oncologist, hematologist, intern, nurse and caregiver in day unit of hospital
Exclusion
Key Trial Info
Start Date :
April 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2021
Estimated Enrollment :
809 Patients enrolled
Trial Details
Trial ID
NCT04366154
Start Date
April 15 2020
End Date
May 1 2021
Last Update
December 14 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre François Baclesse
Caen, France
2
Centre Henri Becquerel
Rouen, France